The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.
作者信息
White A C, Sims A C
出版信息
Curr Med Res Opin. 1974;2(1):23-6. doi: 10.1185/03007997409111736.
PMID:4841811
Abstract
摘要
相似文献
1
The use of an oral long-acting anti-psychotic agent, penfluridol, in schizophrenia.口服长效抗精神病药物五氟利多在精神分裂症中的应用。
Curr Med Res Opin. 1974;2(1):23-6. doi: 10.1185/03007997409111736.
2
Safety evaluation of penfluridol, a new long-acting oral antipsychotic agent.新型长效口服抗精神病药物五氟利多的安全性评估
J Clin Pharmacol. 1974 Apr;14(4):202-9. doi: 10.1002/j.1552-4604.1974.tb01398.x.
3
Penfluridol: a long-acting oral neuroleptic as therapeutic agent in chronic schizophrenia.五氟利多：一种长效口服抗精神病药，用作慢性精神分裂症的治疗药物。
Curr Ther Res Clin Exp. 1974 Oct;16(10):1041-58.
4
5
[Long-acting neuroleptics. 3. Pilot study of penfluridol (R16341): psychometric data].[长效抗精神病药。3. 五氟利多（R16341）的初步研究：心理测量数据]
Acta Psychiatr Belg. 1972 Sep;72(5):595-601.
6
[Aspects of neuroleptic depot therapy with special consideration of clinical experiences with the preoral depot preparation Penfluridol (R 16 341-Jannsen)].
Int Pharmacopsychiatry. 1974;9(3):152-65.
7
[Clinical experiences with an oral, long-term neuroleptic agent: penfluridol].[一种口服长效抗精神病药物：五氟利多的临床经验]
Med Welt. 1973 Apr 13;24(15):600-3.
8
A double-blind clinical evaluation of penfluridol (R 16 341) as a maintenance therapy in schizophrenia.五氟利多（R 16 341）作为精神分裂症维持治疗药物的双盲临床评估。
Acta Psychiatr Scand. 1974;50(3):346-53. doi: 10.1111/j.1600-0447.1974.tb08220.x.
9
Controlled trial of penfluridol in acute psychosis.五氟利多治疗急性精神病的对照试验。
Br Med J. 1971 Dec 18;4(5789):710-3. doi: 10.1136/bmj.4.5789.710.
10
引用本文的文献
1
Penfluridol: an open phase III study in acute newly admitted hospitalized schizophrenic patients.五氟利多：急性新入院住院精神分裂症患者的开放性III期研究。
Psychopharmacology (Berl). 1977 Dec 19;55(2):157-64. doi: 10.1007/BF01457852.
Zotero 插件